DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "European Market Report for Port Needles 2017 - MedCore" report to their offering.
Over the forecast period, the total port needle market is expected to experience growth. The increase in market value will be driven by growth in the size and age of the European population and the corresponding rise in demand for cancer treatment.
Growth will be limited by ASP erosion. Price declines will be driven by competition amongst firms and a lack of technological innovation. Price erosion will be limited by growth in the alternate care market as well as the conversion to safety port needles.
Port needles or Huber needles are used exclusively for accessing implantable ports; therefore, there is a strong correlation between the sales of these two devices.
While ports are primarily implanted in hospitals, port needles are widely used in alternate care sites. Improved designs of port needles are allowing patients to refill and maintain their implantable ports on their own or with minimal help from family or clinical staff. However, many port patients must visit a hospital to receive treatment because they require monitoring or assistance, particularly if their medication has potential side effects.
Key Topics Covered:
Table Of Contents I
List Of Figures Xvi
List Of Charts Xx
European Market For Vascular Access Devices And Accessories Overview
Key Report Updates
3DT Holdings LLC
Vascular Pathways, Inc.
VeriTeQ Acquisition Corp.
For more information about this report visit http://www.researchandmarkets.com/research/qh67w3/european_market